Literature DB >> 24402326

Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.

Christopher Prendergast1, Samuel S Gidding.   

Abstract

The epidemic of childhood obesity worldwide has led to increased incidence of the metabolic syndrome and type 2 diabetes in the pediatric and adolescent population. As such, there is increasing concern that this large population of children is at risk for the long-term complications of diabetes, specifically cardiovascular disease. With cardiovascular disease remaining the leading cause of death in adults, this presents a significant public health concern as these children age. In this article, we discuss cardiovascular disease and risk in children and adolescents with type 2 diabetes, including the epidemiology of type 2 diabetes, atherosclerotic cardiovascular disease, obesity, hypertension, and left ventricular function.

Entities:  

Mesh:

Year:  2014        PMID: 24402326     DOI: 10.1007/s11892-013-0454-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  84 in total

Review 1.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

2.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Authors:  Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

3.  Insulin resistance and arterial stiffness in healthy adolescents and young adults.

Authors:  E M Urbina; Z Gao; P R Khoury; L J Martin; L M Dolan
Journal:  Diabetologia       Date:  2011-12-23       Impact factor: 10.122

4.  Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.

Authors:  Kenneth C Copeland; Philip Zeitler; Mitchell Geffner; Cindy Guandalini; Janine Higgins; Kathryn Hirst; Francine R Kaufman; Barbara Linder; Santica Marcovina; Paul McGuigan; Laura Pyle; William Tamborlane; Steven Willi
Journal:  J Clin Endocrinol Metab       Date:  2010-10-20       Impact factor: 5.958

5.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

6.  Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study.

Authors:  R E Tracy; W P Newman; W A Wattigney; G S Berenson
Journal:  Am J Med Sci       Date:  1995-12       Impact factor: 2.378

7.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

8.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

Review 9.  Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

10.  Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial.

Authors: 
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

View more
  7 in total

1.  Weight status, gender, and race/ethnicity: are there differences in meeting recommended health behavior guidelines for adolescents?

Authors:  Karl E Minges; Ariana Chao; Soohyun Nam; Margaret Grey; Robin Whittemore
Journal:  J Sch Nurs       Date:  2014-10-13       Impact factor: 2.835

2.  Leveraging Delivery of Blood Pressure Control Interventions among Low-income African American Adults: Opportunities to Increase Social Support and Produce Family-level Behavior Change.

Authors:  Tracy J Yang; Lisa A Cooper; L Ebony Boulware; Rachel L J Thornton
Journal:  Ethn Dis       Date:  2019-10-17       Impact factor: 1.847

3.  Strain-specific Differences in the Effects of Lymphocytes on the Development of Insulin Resistance and Obesity in Mice.

Authors:  Elisavet Kodela; Maria Moysidou; Sevasti Karaliota; Yassemi Koutmani; Panagiotis Tsakanikas; Konstantia Kodella; Eleni A Karavia; Kyriakos E Kypreos; Nikolaos Kostomitsopoulos; Katia P Karalis
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

4.  Obesity and insulin sensitivity effects on cardiovascular risk factors: Comparisons of obese dysglycemic youth and adults.

Authors: 
Journal:  Pediatr Diabetes       Date:  2019-07-29       Impact factor: 4.866

5.  Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability.

Authors:  Paul D Chantler; Carl D Shrader; Lawrence E Tabone; Alexandre C d'Audiffret; Khumara Huseynova; Steven D Brooks; Kayla W Branyan; Kristin A Grogg; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2015-08       Impact factor: 2.628

6.  Associations between lead concentrations and cardiovascular risk factors in U.S. adolescents.

Authors:  Cheng Xu; Yaqin Shu; Zhi Fu; Yuanli Hu; Xuming Mo
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

7.  Multiple cardiovascular risk factors in adolescents from a middle-income country: Prevalence and associated factors.

Authors:  Thiago Veiga Jardim; Thomas A Gaziano; Flávia Miquetichuc Nascente; Carolina de Souza Carneiro; Polyana Morais; Vanessa Roriz; Karla Lorena Mendonça; Thaís Inácio Rolim Póvoa; Weimar Kunz Sebba Barroso; Ana Luiza Lima Sousa; Paulo César Brandão Veiga Jardim
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.